Company Filing History:
Years Active: 1994-1995
Title: Innovations by Margarita Vildaver
Introduction
Margarita Vildaver is a notable inventor based in Napa, California. She has made significant contributions to the field of ophthalmic medicaments, holding 2 patents that showcase her innovative spirit and dedication to improving healthcare.
Latest Patents
Her latest patents focus on alkaline ophthalmic suspensions, which are topical ophthalmic medicament delivery systems. These systems combine an aqueous ophthalmic gel suspension at a pH equal to or greater than 7.5 and an osmotic pressure ranging from 10 to about 400 mOsM. They contain a pharmaceutically effective amount of one or more ophthalmic medicaments, with concentrations from about 0.05% to about 10% by weight. The formulation includes a carboxyl-containing polymer prepared by polymerizing one or more carboxyl-containing monoethylenically unsaturated monomers, along with less than about 5% by weight of a cross-linking agent. The systems exhibit a viscosity of about 1,000 to about 30,000 centipoises prior to administration and maintain a gel-like consistency in the eye for an extended period, allowing for the sustained release of medicaments such as amine-containing antibiotics, either alone or in combination with corticosteroids.
Career Highlights
Margarita Vildaver is associated with Insite Vision Corporation, where she continues to develop innovative solutions in ophthalmology. Her work has significantly impacted the delivery of ophthalmic medications, enhancing patient care and treatment outcomes.
Collaborations
She has collaborated with esteemed colleagues, including Rajesh A Patel and Lyle M Bowman, contributing to a dynamic and innovative work environment.
Conclusion
Margarita Vildaver's contributions to ophthalmic medicament delivery systems exemplify her commitment to innovation in healthcare. Her patents reflect a deep understanding of the complexities involved in drug delivery, ultimately benefiting patients in need of effective treatments.